Bleeding, blood transfusion, and increased mortality after percutaneous coronary intervention: implications for contemporary practice
BJ Doyle, CS Rihal, DA Gastineau… - Journal of the American …, 2009 - jacc.org
Advances in percutaneous coronary intervention (PCI) during the past decade have led to
more widespread use of these procedures in older and sicker patients. Refinement of …
more widespread use of these procedures in older and sicker patients. Refinement of …
Prospective, randomised trial of two doses of rFVIIa (NovoSeven) in haemophilia patients with inhibitors undergoing surgery
AD Shapiro, GS Gilchrist, WK Hoots… - Thrombosis and …, 1998 - thieme-connect.com
Recombinant factor VIIa (rFVIIa; NovoSeven®; Novo Nordisk) has proven efficacy in the
treatment of haemophilic patients with inhibitors. This prospective, double-blind study …
treatment of haemophilic patients with inhibitors. This prospective, double-blind study …
[HTML][HTML] The CD14+ HLA-DRlo/neg monocyte: an immunosuppressive phenotype that restrains responses to cancer immunotherapy
AE Mengos, DA Gastineau, MP Gustafson - Frontiers in immunology, 2019 - frontiersin.org
Recent successes in cancer immunotherapy have been tempered by sub-optimal clinical
responses in the majority of patients. The impaired anti-tumor immune responses observed …
responses in the majority of patients. The impaired anti-tumor immune responses observed …
Prognostication of survival using cardiac troponins and N-terminal pro-brain natriuretic peptide in patients with primary systemic amyloidosis undergoing peripheral …
Primary systemic amyloidosis (AL) is a fatal plasma cell disorder. Pilot data suggest survival
is better in patients undergoing peripheral blood stem cell transplantation (PBSCT), but the …
is better in patients undergoing peripheral blood stem cell transplantation (PBSCT), but the …
Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation in multiple myeloma or non-Hodgkin lymphoma
LF Porrata, MA Gertz, DJ Inwards… - Blood, The Journal …, 2001 - ashpublications.org
Autologous stem cell transplantation (ASCT) improves survival in patients with previously
untreated multiple myeloma (MM) and relapsed, chemotherapy-sensitive, aggressive non …
untreated multiple myeloma (MM) and relapsed, chemotherapy-sensitive, aggressive non …
Superior survival in primary systemic amyloidosis patients undergoing peripheral blood stem cell transplantation: a case-control study
Primary systemic amyloidosis (AL) is a plasma cell dyscrasia resulting in multisystem failure
and death. High-dose chemotherapy with peripheral blood stem cell transplantation …
and death. High-dose chemotherapy with peripheral blood stem cell transplantation …
Priming tissue-specific cellular immunity in a phase I trial of autologous dendritic cells for prostate cancer
PA Burch, JK Breen, JC Buckner, DA Gastineau… - Clinical Cancer …, 2000 - AACR
We attempted to induce therapeutic immunity against prostate-derived tissues in patients
suffering from progressive hormone-refractory metastatic prostate carcinoma. Thirteen …
suffering from progressive hormone-refractory metastatic prostate carcinoma. Thirteen …
Immunosuppressive CD14+HLA-DRlow/− monocytes in B-cell non-Hodgkin lymphoma
Y Lin, MP Gustafson, PA Bulur… - Blood, The Journal …, 2011 - ashpublications.org
Immunosuppression is a known risk factor for B-cell non-Hodgkin lymphoma (NHL), yet
mechanisms of tumor-associated immunosuppression remain to be fully characterized. We …
mechanisms of tumor-associated immunosuppression remain to be fully characterized. We …
Systemic immune suppression in glioblastoma: the interplay between CD14+HLA-DRlo/neg monocytes, tumor factors, and dexamethasone
MP Gustafson, Y Lin, KC New, PA Bulur… - Neuro …, 2010 - academic.oup.com
Patients with glioblastoma (GBM) exhibit profound systemic immune defects that affect the
success of conventional and immune-based treatments. A better understanding of the …
success of conventional and immune-based treatments. A better understanding of the …
Late‐onset noninfectious pulmonary complications after allogeneic bone marrow transplantation
We examined the incidence and clinical outcome of late‐onset noninfectious pulmonary
complications (LONIPC) in a series of 234 patients who underwent allogeneic bone marrow …
complications (LONIPC) in a series of 234 patients who underwent allogeneic bone marrow …